Individual Stock Analysis
Haleon (HLN): What the Fundamentals Show in the Medicine Cabinet
This Haleon stock analysis covers the consumer health group behind Sensodyne and Panadol: FY2025 and H1 2026 figures, margins, dividend and risks.
Andrew Menzies·17 Sept 2026